Reversal of hypereosinophilic syndrome and lymphomatoid papulosis with mepolizumab and imatinib.
Mark J
MJ
Koury
John H
JH
Newman
John J
JJ
Murray
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D001549:Benzamides; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D017681:Hypereosinophilic Syndrome / Q000188:drug therapy*; D000068877:Imatinib Mesylate; D015848:Interleukin-5 / Q000097:blood; D017731:Lymphomatoid Papulosis / Q000188:drug therapy*; D008875:Middle Aged; D010879:Piperazines / Q000627:therapeutic use*; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors; D011743:Pyrimidines / Q000627:therapeutic use*
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D001549:Benzamides; D015848:Interleukin-5; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate; C434107:mepolizumab; D011505:Protein-Tyrosine Kinases